Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a condition that causes scarring or inflammation in the lungs (known as interstitial lung disease), based on medical imaging, breathing tests, and/or tissue samples.
- People who have chest CT scan image files and breathing test results available, with both tests done within two weeks of each other.
Who may not be able to join:
- People who are pregnant.
- People who have fluid build-up in the lungs (pulmonary edema).
- People who have high blood pressure in the arteries of the lungs that is not caused by another condition (primary pulmonary hypertension).
- People who have a long-term lung condition that blocks airflow, such as emphysema or chronic bronchitis (chronic obstructive pulmonary disease).
- People who have a condition where the heart cannot pump blood effectively enough to meet the body's needs (congestive heart failure).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ramy M Ahmed, MD, Assiut University
Phone: +201153070865
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
CT visual Warrick score (measured by points); Total lung volume, Volume of lung occupied by low attenuation areas, Volume of lung occupied by high attenuation areas, Volume of normal lung areas and volume of consolidation areas; Percentage of the lung occupied by low attenuation areas, percentage of normal lung, percentage of the lung occupied by high attenuation areas and percentage of consolidation areas.; Mean lung density of each lung, both lungs and every lobe in Hounsfield unit (HU); Forced vital capacity (FVC); Forced expiratory volume in 1 second (FEV1); FEV1/FVC ratio; O2 saturation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.